Quarterly ResultAug 5, 2026, 01:44 PM
Edgewell Q3 Net Loss $(62.6)M; Sales Up 1.36% YTD
AI Summary
Edgewell Personal Care reported a net loss of $(62.6)M for the nine months ended June 30, 2026, a significant decline from net earnings of $56.0M in the prior year, primarily due to losses from discontinued operations and impairment charges. Net sales for the nine-month period saw a modest increase of 1.36% to $1,512.4M. The company completed the divestiture of its Feminine Care segment for $340.0M, which included a $37.4M goodwill impairment charge, and continued with significant restructuring initiatives totaling $71.9M in charges. Despite the net loss, Edgewell increased cash and cash equivalents to $397.1M and reduced long-term debt by $138.3M.
Key Highlights
- Net loss of $(62.6)M for nine months ended June 30, 2026, compared to net earnings of $56.0M in prior year.
- Diluted EPS was $(1.35) for nine months ended June 30, 2026, down from $1.17 in prior year.
- Net sales increased 1.36% to $1,512.4M for the nine months ended June 30, 2026.
- Completed Feminine Care segment divestiture for $340.0M, incurring $37.4M goodwill impairment.
- Total restructuring charges amounted to $71.9M for the nine months ended June 30, 2026.
- Cash and cash equivalents increased to $397.1M from $225.7M since September 30, 2025.
- Long-term debt decreased by $138.3M to $1,245.0M since September 30, 2025.
Price Impact
More from EPC